These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 10464023)
1. Probing the topological arrangement of the N- and C-terminal residues of bradykinin for agonist activity at the B1 receptor. Pellegrini M; Tancredi M; Rovero P; Mierke DF J Med Chem; 1999 Aug; 42(17):3369-77. PubMed ID: 10464023 [TBL] [Abstract][Full Text] [Related]
2. Structural characterization of lipopeptide agonists for the bradykinin B2 receptor. Giragossian C; Nardi E; Savery C; Pellegrini M; Meini S; Maggi CA; Papini AM; Mierke DF Biopolymers; 2001 Apr; 58(5):511-20. PubMed ID: 11241222 [TBL] [Abstract][Full Text] [Related]
3. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins. Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241 [TBL] [Abstract][Full Text] [Related]
4. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor. Fathy DB; Kyle DJ; Leeb-Lundberg LM Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692 [TBL] [Abstract][Full Text] [Related]
5. Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptide. Rovero P; Pellegrini M; Di Fenza A; Meini S; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mierke DF J Med Chem; 2001 Jan; 44(2):274-8. PubMed ID: 11170638 [TBL] [Abstract][Full Text] [Related]
6. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity. Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478 [TBL] [Abstract][Full Text] [Related]
7. A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers. Galoppini C; Meini S; Tancredi M; Di Fenza A; Triolo A; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mazzucco S; Papini A; Rovero P J Med Chem; 1999 Feb; 42(3):409-14. PubMed ID: 9986712 [TBL] [Abstract][Full Text] [Related]
8. New conformationally homogeneous beta-turn antagonists of the human B2 kinin receptor. Monteagudo ES; Calvani F; Catrambone F; Fincham CI; Madami A; Meini S; Terracciano R J Pept Sci; 2001 May; 7(5):270-83. PubMed ID: 11428548 [TBL] [Abstract][Full Text] [Related]
9. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity. Miskolzie M; Gera L; Stewart JM; Kotovych G J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620 [TBL] [Abstract][Full Text] [Related]
10. A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1-specific receptor antagonists B-9430, B-9436, and B-9858. Sejbal J; Wang Y; Cann JR; Stewart JM; Gera L; Kotovych G Biopolymers; 1997 Oct; 42(5):521-35. PubMed ID: 9322442 [TBL] [Abstract][Full Text] [Related]
11. Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues. Wille PR; Vitor R; Gabilan NH; Nicolau M Mediators Inflamm; 2001 Jun; 10(3):163-7. PubMed ID: 11545253 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist. Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953 [TBL] [Abstract][Full Text] [Related]
13. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta. Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764 [TBL] [Abstract][Full Text] [Related]
14. Novel pseudopeptides with high affinities for the human bradykinin B2 receptor. Chakravarty S; Connolly M; Kyle DJ Pept Res; 1995; 8(1):16-9. PubMed ID: 7756750 [TBL] [Abstract][Full Text] [Related]
15. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan. Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212 [TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors. Hess JF; Hey PJ; Chen TB; O'Brien J; Omalley SS; Pettibone DJ; Chang RS Biol Chem; 2001 Jan; 382(1):123-9. PubMed ID: 11258662 [TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional regulation of bradykinin B1 and B2 receptor gene expression in human lung fibroblasts by tumor necrosis factor-alpha: modulation by dexamethasone. Haddad EB; Fox AJ; Rousell J; Burgess G; McIntyre P; Barnes PJ; Chung KF Mol Pharmacol; 2000 Jun; 57(6):1123-31. PubMed ID: 10825382 [TBL] [Abstract][Full Text] [Related]